BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1347754)

  • 1. T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients.
    Alam SM; Clark JS; Leech V; Whitford P; George WD; Campbell AM
    Immunol Lett; 1992 Feb; 31(3):279-83. PubMed ID: 1347754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes.
    Watanabe N; Hizuta A; Tanaka N; Orita K
    Clin Exp Immunol; 1995 Oct; 102(1):167-73. PubMed ID: 7554384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Immunol Lett; 1996 Oct; 53(1):15-8. PubMed ID: 8946212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium.
    Halstensen TS; Brandtzaeg P
    Eur J Immunol; 1993 Feb; 23(2):505-10. PubMed ID: 8094672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of membrane TcR alpha beta and TcR gamma delta chain expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+ and CD4-CD8- lymphocytes.
    Scott CS; Richards SJ; Roberts BE
    Immunology; 1990 Jul; 70(3):351-6. PubMed ID: 2143170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
    Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
    Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V delta 2+ gamma delta T lymphocytes are cytotoxic to the MCF 7 breast carcinoma cell line and can be detected among the T cells that infiltrate breast tumors.
    Bank I; Book M; Huszar M; Baram Y; Schnirer I; Brenner H
    Clin Immunol Immunopathol; 1993 Apr; 67(1):17-24. PubMed ID: 8443981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.
    Macchetti AH; Marana HR; Silva JS; de Andrade JM; Ribeiro-Silva A; Bighetti S
    Clinics (Sao Paulo); 2006 Jun; 61(3):203-8. PubMed ID: 16832552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a bovine surface antigen uniquely expressed on CD4-CD8- T cell receptor gamma/delta+ T lymphocytes.
    Clevers H; MacHugh ND; Bensaid A; Dunlap S; Baldwin CL; Kaushal A; Iams K; Howard CJ; Morrison WI
    Eur J Immunol; 1990 Apr; 20(4):809-17. PubMed ID: 1971793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory function of CD3+, CD4-, and CD8- T cells. Gamma delta T cell receptor-positive T cells from nude mice abrogate oral tolerance.
    Fujihashi K; Kiyono H; Aicher WK; Green DR; Singh B; Eldridge JH; McGhee JR
    J Immunol; 1989 Dec; 143(11):3415-22. PubMed ID: 2573632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood.
    Inghirami G; Zhu BY; Chess L; Knowles DM
    Am J Pathol; 1990 Feb; 136(2):357-67. PubMed ID: 2137673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered lymphocyte populations in tumour invaded nodes of breast cancer patients.
    Alam SM; Clark JS; George WD; Campbell AM
    Immunol Lett; 1993 Mar; 35(3):229-34. PubMed ID: 8390399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer.
    Rubbert A; Manger B; Lang N; Kalden JR; Platzer E
    Int J Cancer; 1991 Aug; 49(1):25-31. PubMed ID: 1908441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
    Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
    J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and expression of the human T cell receptor-T3 complex by monoclonal antibody F101.01.
    Geisler C; Plesner T; Pallesen G; Skjødt K; Odum N; Larsen JK
    Scand J Immunol; 1988 Jun; 27(6):685-96. PubMed ID: 2969142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.